Track record · closed signal

The Interpublic Group of Companies, Inc. (IPG) — closed signal from October 3, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 1, 2026.

Predicted vs. what happened

IPG price · publication thesis → realized outcomesplit-adjusted
$26.59 Published $30.57 Target $24.57 Window close $28.24 Peak
$26.00 – $27.00Entry zone — fair-value band
$26.59Published — price the day we called it
$30.57Target — the price the thesis aimed for
$28.24Peak — highest point inside the window, not a realized return
$24.57Window close — end-of-window price, context only

What happened

Partial

Reached 41% of the predicted growth at its peak, without hitting the target.

Peak price
$28.24
peak on October 22, 2025 — not a realized return
Peak gain
+6.2%
peak, from the publication price
Window close
$24.57
end-of-window price, context only
Days to target
Window
October 3, 2025 – January 1, 2026

The thesis — published October 3, 2025

Predicted growth
+15%
over the measurement window
Target price
$30.57
the price the thesis aimed for
Entry zone
$26.00 – $27.00
the fair-value band we waited for
Price at publication
$26.59
published October 3, 2025
Confidence
74%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

IPG looks ready for a bounce after a long slide. Recent price action suggests the selloff may be easing and buyers are starting to show up. A big win with Bayer's global marketing work and fresh quality certifications add proof the business can execute. If the overall market stays steady, ad budgets could level out, giving the stock room to recover over the next three months. Main risks are weaker ad demand and currency swings.

Primary drivers

  • Price slump looks overdone; fresh signs show buyers stepping back in.
  • Winning Bayer's global marketing work boosts credibility and future fees.
  • New ISO quality certifications confirm strong, consistent processes.
  • If companies stop cutting ads, revenue can steady and support a rebound.

How it played out

IPG: the thesis did not reach its target

Lyra published IPG at $26.59 on 2025-10-03 with a short-term bounce thesis. It expected 15% growth to $30.57. The thesis pointed to an overdone price slump, signs of buyers returning, Bayer's global marketing work, ISO quality certifications, and steadier ad budgets if companies stopped cutting ads.

Inside the window, IPG rose to a peak of $28.24 on 2025-10-22, a 6.2% gain. It stayed below the $30.57 target and never reached it. By 2026-01-01, it ended at $24.57. The thesis partially played out early, but it missed the target.

What happened during the window

On 2025-11-26, Omnicom completed its acquisition of Interpublic Group. On 2025-12-02, Axios reported that Omnicom planned about 4,000 layoffs after the IPG deal.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.